Enlivex Therapeutics Ltd
(ENLV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,048 | 15,142 | 9,736 | 11,351 | 1,674 |
| Marketable Securities | 41 | 40 | 40 | 40 | N/A |
| Receivables | 2,751 | 2,092 | 213 | 161 | 30 |
| TOTAL | $19,578 | $17,778 | $10,277 | $11,590 | $1,704 |
| Non-Current Assets | |||||
| PPE Net | 758 | 742 | 685 | 469 | N/A |
| Other Non-Current Assets | 493 | 526 | 72 | 71 | 0 |
| TOTAL | $1,251 | $1,268 | $757 | $540 | $N/A |
| Total Assets | $20,829 | $19,046 | $11,034 | $12,130 | $1,704 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 335 | 293 | 186 | 151 | 144 |
| Accrued Expenses | 1,364 | 899 | 944 | 809 | N/A |
| Other current liabilities | 3,500 | 3,500 | N/A | N/A | N/A |
| TOTAL | $5,199 | $4,692 | $1,130 | $960 | $144 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 269 | 898 | 198 | 262 | 0 |
| TOTAL | $269 | $898 | $198 | $262 | $N/A |
| Total Liabilities | $5,468 | $5,590 | $1,328 | $1,222 | $144 |
| Shareholders' Equity | |||||
| Common Shares | 1,126 | 1,099 | 396 | 204 | 46 |
| Retained earnings | -20,415 | -18,954 | -16,289 | -14,704 | -47,448 |
| Other shareholders' equity | -1,717 | -1,951 | -2,251 | -1,916 | 0 |
| TOTAL | $15,361 | $13,456 | $9,706 | $10,908 | $1,560 |
| Total Liabilities And Equity | $20,829 | $19,046 | $11,034 | $12,130 | $1,704 |